Literature DB >> 3813851

Indications for the application of Wagner's method of external fixation across the knee joint.

H J Klasen, K W Zimmerman, H J ten Duis.   

Abstract

External fixation with Wagner's apparatus can, because of its mechanical properties, be employed for temporary immobilization of the knee joint. This method is especially suitable for patients for whom immobilization in plaster is problematic or disadvantageous. It can be applied to the following categories of patients: Patients with injuries to the bones or ligaments of the knee which are associated with wounds or injuries of the blood vessels or nerves; Patients with multiple injuries of the leg (e.g., fractures of the tibia and femur) and concomitant intra-articular knee injuries; Patients with a septic arthritis of the knee joint.

Entities:  

Mesh:

Year:  1986        PMID: 3813851     DOI: 10.1007/bf00449944

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  5 in total

1.  [Surgical leg prolongation].

Authors:  H Wagner
Journal:  Chirurg       Date:  1971-06       Impact factor: 0.955

2.  [Functional treatment of fractures using the lengthening apparatus].

Authors:  H Wagner; G Zeiler
Journal:  Orthopade       Date:  1983-05       Impact factor: 1.087

3.  External fixation. Classification and indications.

Authors:  G Hierholzer; R Kleining; G Hörster; P Zemenides
Journal:  Arch Orthop Trauma Surg       Date:  1978-08-30

4.  Equalisation of leg length.

Authors:  P C Armour; J H Scott
Journal:  J Bone Joint Surg Br       Date:  1981

5.  Lengthening of the lower extremity by the Wagner method. A review of the Boston Children's Hospital Experience.

Authors:  R W Hood; E J Riseborough
Journal:  J Bone Joint Surg Am       Date:  1981-09       Impact factor: 5.284

  5 in total
  1 in total

1.  [External fixation with motion capacity in complex dislocation of the knee joint and associated injuries].

Authors:  T C Koslowsky; R Schadt; K Mader; D Pennig
Journal:  Unfallchirurg       Date:  2011-02       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.